Navigation Links
Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
Date:10/2/2008

GOTEBORG, Sweden, October 2 /PRNewswire/ -- Calabar AB announced today that their Phase II repeated dose study in xerostomia ("dry mouth") patients has been initiated. Specifically, the drug will be studied in 45 dry mouth patients between the ages of 20 to 75. The objective of the study is to select a dose for evaluation in a succeeding Phase III efficacy study.

Xalieve(TM) is a gel containing the cholinesterase inhibitor physostigmine. It is administered locally in the mouth where physostigmine diffuses through the mucosa reaching the minor glands. By inhibiting cholinesterase, acetylcholine accumulates and the elevated concentrations stimulate the muscarinic receptors in the minor glands, improving saliva production. Unlike systemically administered drugs, the local route of administration limits adverse events.

"Xalieve(TM) offers a completely new approach in treating dry mouth and we are very excited about this Phase II study," said Mr. Fredrik Rook, VP Business Development of Calabar. "Xerostomia is not getting the attention it deserves. These patients are experiencing dramatic decrease in quality of life, such as difficulty in swallowing and speaking, and a burning sensation in the mouth. Xalieve(TM) has the possibility to radically improve the life of millions of people suffering from dry mouth."

About Calabar AB:

Calabar is a privately-held company committed to developing pharmaceutical products addressing the significant unmet needs of xerostomia "dry mouth". The company's product Xalieve(TM) is a locally administered formulation of the cholinesterase inhibitor physostigmine, which has been shown to effectively increase salivary flow. The company is part of the Karolinska Development AB portfolio. For more information, please visit http://www.calabar.se

Contact:

VP Business Development,

Fredrik Rook,

+46-8-524-860-38,


SOURCE Calabar AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
2. Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus
3. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
4. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
5. Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
6. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
7. Novel Approach May Protect Against Heart Attack Injury
8. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
9. Grocery Manufacturers Association: Study Signals Progress in Battle Against Obesity
10. Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... 2014  HealthLoop® released an app version of its ... 8 and allows people to share medical device and ... iOS technologies to enhance the HealthLoop experience for iPhone ... their doctors between visits. "This new ... collect is exciting," says HealthLoop founder Dr. Jordan ...
(Date:9/30/2014)... 2014  Georgia-Pacific Professional is a leading provider ... a wide range of away from home applications. ... in healthcare, including hospitals, long-term care facilities, surgical ... its healthcare products and solutions to the dental ... of infection control in the dental office," said ...
Breaking Medicine Technology:New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
(Date:9/30/2014)... 30, 2014 Dr. Karl R.O.S. Johnson, ... program of care that is dramatically improving the ... clinic—Johnson Chiropractic Neurology & Nutrition—applies a proprietary, multi-dimensional approach ... also addresses sources of inflammation, neurology of the joint ... chain” from the brain to the spine, to the ...
(Date:9/30/2014)... Bifidobacteria, the primary bacteria found in the large ... so a high Bifido probiotic can help replenish this ... Men’s Complete contains 90 Billion live probiotic cultures, ... support a healthy large intestine (colon) where elimination occurs ... cultures from 7 Lactobacillus strains to help maintain a ...
(Date:9/30/2014)... 2014) Levothyroxine is considered the gold standard therapy ... review of therapies for the condition including combining ... assessment, say a team of investigators.,1Their analysis, published as ... , finds insufficient consistent data exist to recommend a ... sold under various trade names, such as Synthroid ...
(Date:9/30/2014)... Department of Defense (DoD) is being launched to ... may lead to the first successful treatments for ... athletes and soldiers, but also millions among the ... , Under the partnership, officially launched October 1, ... the DoD, the research team, representing many universities, ...
Breaking Medicine News(10 mins):Health News:Regenerative Medicine Solutions Expanding 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3Health News:ReNew Life Introduces Ultimate Flora™ Men’s Complete Probiotic 90 Billion—Comprehensive Probiotic Support Just for Men 2Health News:New guidelines for treatment of hypothyroidism endorse current therapy 2Health News:US aims for traumatic brain injury clinical trial success 2Health News:US aims for traumatic brain injury clinical trial success 3Health News:US aims for traumatic brain injury clinical trial success 4
... Healthy Snacking, MINDEN, Nev., April 22 Nutrition ... Detour(R) bar, today announced,the introduction of a convenient new ... Bar(TM). The snack size bar is loaded with,essential nutrients ... a,healthy lifestyle. With seven grams of protein and just ...
... Fla., April 22 Applying the Family and Medical,Leave ... the country. A recent change and several proposed amendments ... and will clarify,application of the Act in both civilian ... employers must grant eligible,employees up to a total of ...
... BEHAVIORAL ... CARE SERVICES ACROSS NEW MEXICO, ALBUQUERQUE, N.M., April ... that serves the New Mexico,Behavioral Health Collaborative, announced it ... providers to further develop,community-based services across the state. This ...
... report from the American Cancer Society highlights that long-term ... been responsible for declining cancer death rates in the ... and Figures 2008 (CPED), points out that drops in ... rates have been stable or slightly declining since 2000 ...
... treatment with chemotherapeutic agents is often associated with ... referred to as chemobrain - that may compromise ... cancer survivors. Now, research published in the open ... a single chemotherapeutic agent, 5-fluorouracil (5-FU), by itself ...
... ,biological mechanism, that leads to adverse reactions identified, officials ... heparin products have now been found in at least ... ongoing surveillance measures to ensure the safety of the ... addition, officials said contaminated lots of the blood thinner ...
Cached Medicine News:Health News:Detour(R) Unveils Snack Size Protein Bar 2Health News:Changes to Family and Medical Leave Act Clarify Employer Responsibilities 2Health News:Changes to Family and Medical Leave Act Clarify Employer Responsibilities 3Health News:ValueOptions(R) New Mexico Provides $10.3 Million for Community Behavioral Health Care Organizations 2Health News:American Cancer Society report details cancer prevention efforts 2Health News:American Cancer Society report details cancer prevention efforts 3Health News:American Cancer Society report details cancer prevention efforts 4Health News:Chemotherapy causes delayed severe neural damage 2Health News:FDA: Contaminated Heparin Found in 10 Countries 2Health News:FDA: Contaminated Heparin Found in 10 Countries 3Health News:FDA: Contaminated Heparin Found in 10 Countries 4
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: